Press release, September 08, 2009
APEPTICO presents its lead product AP301
at the Annual Congress of the European Respiratory Society in Vienna, Austria
[more]
Press release, August 11, 2009
Adriacell Closing of A Round Financing
11th August 2009, Trieste – Italy: Adriacell, a preclinical, oncology-focused biotech company
announced the completion of A round financing.
[more]
Press release, July 20, 2009
APEPTICO granted Orphan Medicinal Product Designation
by EMEA for lead product AP301
[more]
Press release, June 9, 2009
APEPTICO GmbH erhält Preis anlässlich der Verleihung des
“Venture Capital & Private Equity Award Österreichs“
[more]
Press release, May 29, 2009
APEPTICO GmbH closes seed financing round
[more]
March 23, 2009
ugichem to enter into research collaboration with Santhera Pharmaceuticals to evaluate and apply ugichem’s
oligonucleotide platform technology in the field of rare neuromuscular diseases
[more]
Press release, October 27, 2008
Starke Wachstumsaussichten für den Nanomedizin-Spezialisten
[more]
Press release, June 10, 2008
Seed-Fonds Aachen and The BioScience Ventures Group invest in MaRVis Technologies GmbH Seed capital for the development of MRI compatible and visible medical devices